CEFDINIR LACTONE

Details

Stereochemistry	EPIMERIC
Molecular Formula	C14H13N5O5S2
Molecular Weight	395.414
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 3
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1OC(=O)C2=C1CS[C@@H]3[C@H](NC(=O)C(=N/O)\C4=CSC(N)=N4)C(=O)N23

InChI

InChIKey=UEHIFMGCXPDQOP-CXMNRGBSSA-N

InChI=1S/C14H13N5O5S2/c1-4-5-2-25-12-8(11(21)19(12)9(5)13(22)24-4)17-10(20)7(18-23)6-3-26-14(15)16-6/h3-4,8,12,23H,2H2,1H3,(H2,15,16)(H,17,20)/b18-7-/t4?,8-,12-/m1/s1

HIDE SMILES / InChI

Description
Sources: https://www.clearsynth.com/en/CST10734.html

There is no information related the biological and pharmacological application of cefdinir lactone but it’s known that this compound is an admixture of cefdinir, that is why it’s also called as cefdinir impurity E.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

CEFDINIR LACTONE

Common Name

English

(Z )-2-(2-AMINOTHIAZOL-4-YL)-2-(HYDROXYIMINO)-N -((3RS ,5AR ,6R )-3-METHYL-1,7-DIOXO-1,3,4,5A,6,7-HEXAHYDROAZETO(2,1-B )FURO(3,4-D )(1,3)THIAZIN-6-YL(ACETAMIDE

Preferred Name

English

CEFDINIR IMPURITY E

Common Name

English

Code System Code Type Description

FDA UNII

0W2W754Q55

Created by admin on Mon Mar 31 21:43:08 GMT 2025 , Edited by admin on Mon Mar 31 21:43:08 GMT 2025

PRIMARY

PUBCHEM

87815632

Created by admin on Mon Mar 31 21:43:08 GMT 2025 , Edited by admin on Mon Mar 31 21:43:08 GMT 2025

PRIMARY

SUBSTANCE RECORD


					0W2W754Q55

CEFDINIR LACTONE

Details

SMILES

InChI

DescriptionSources: https://www.clearsynth.com/en/CST10734.html

Approval Year

Conditions

Sample Use Guides

Description
Sources: https://www.clearsynth.com/en/CST10734.html